Prophylactic use of monophosphoryl lipid a in patients at risk for sepsis
Rudbach, J.A.; Myers, K.R.; Rechtman, D.J.; Ulrich, J.T.
Progress in Clinical and Biological Research 388: 107-124
1994
ISSN/ISBN: 0361-7742 PMID: 7831353 Document Number: 437220
Document emailed within 1 workday
Related Documents
Carpati, C.M.; Astiz, M.E.; Rackow, E.C.; Kim, J.W.; Kim, Y.B.; Weil, M.H. 1992: Monophosphoryl lipid a attenuates the effects of endotoxic shock in pigs Journal of Laboratory and Clinical Medicine 119(4): 346-353Imani Fooladi, A.A.; Sattari, M.; Reza Nourani, M. 2010: Synergistic effects between Staphylococcal enterotoxin type B and Monophosphoryl lipid a against mouse fibrosarcoma Journal of Buon: Official Journal of the Balkan Union of Oncology 15(2): 340-347
Musarra, A.; Bignardi, D.; Troise, C.; Passalacqua, G. 2010: Long-lasting effect of a monophosphoryl lipid-adjuvanted immunotherapy to parietaria. a controlled field study European Annals of Allergy and Clinical Immunology 42(3): 115-119
Astiz, M.E.; Rackow, E.C.; Still, J.G.; Howell, S.T.; Cato, A.; Von Eschen, K.B.; Ulrich, J.T.; Rudbach, J.A.; McMahon, G.; Vargas, R. 1995: Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial Critical Care Medicine 23(1): 9-17
Trudel, J.L.; Thompson, A.G.; Brown, R.A. 1984: Prophylactic use of antibiotics in pancreatic sepsis: a 25-year reappraisal Canadian Journal of Surgery. Journal Canadien de Chirurgie 27(6): 567-570
Baltás, B.; Nagy, A.; Baradnay, G.; Pepó, J. 1980: Experience with prophylactic cimetidine therapy in high risk patients Orvosi Hetilap 121(50): 3043-3047
Møller, M.; Haghfelt, T. 2000: Primary prophylactic treatment with implantable defibrillator in high risk patients Ugeskrift for Laeger 162(31): 4160-4161
Freeman, G.M. 1982: The efficacy of prophylactic antibiotics in high-risk patients undergoing cesarean section Journal of the American Osteopathic Association 81(9): 610-615
Geng, S.; Feng, F.-z.; Xiang, Y.; Wan, X.-r.; Zhou, Y. 2011: Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole Zhonghua Fu Chan Ke Za Zhi 46(1): 24-27
Sleigh, J.W.; Labusch, D.; Loose, R.; Chinyanga, H.M. 1989: Abdominal sepsis: the identification of a high risk subgroup using the APACHE Ii system in twenty-seven patients Central African Journal of Medicine 35(6): 410-413
Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, J.C.; Offenstadt, G.; Régnier, B. 1995: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274(12): 968-974
Vijayasree, M. 2016: Efficacy of Prophylactic B-Lynch Suture during Lower Segment Caesarian Section in High Risk Patients for Atonic Postpartum Haemorrhage Kathmandu University Medical Journal 14(53): 9-12
Kaneko, T.; Hayashida, M.; Saito, Y.; Hikawa, Y.; Yasuda, K. 2000: The effect of prophylactic nicorandil infusion to reduce intraoperative myocardial ischemia during abdominal surgery in patients with risk factors of ischemic heart disease Masui. Japanese Journal of Anesthesiology 49(1): 54-59
Bergesio, F.; Ciuti, R.; Salvadori, M.; Galli, G.A.; Monzani, G.; Bertoni, E.; Salerno, A.; Frizzi, V. 1989: Are lipid abnormalities reliable cardiovascular risk factors in dialysis patients? International Journal of Artificial Organs 12(11): 677-682
Anggara, M.Y.; Gurnida, D.A.; Effendi, S.H. 2014: Correlation between neopterin levels in premature infants with sepsis and the signs and symptoms of neonatal sepsis using the Töllner sepsis score Pteridines 25(2): 49-52
Polozhentsev, S.D.; Rudnev, D.A. 1988: Status of lipid metabolism in patients with ischemic heart disease and its behavioral risk factor Kardiologiia 28(12): 101-102
Basoli, A.; Schietroma, M.; Fiocca, F.; Vigliardi, G.; Speranza, V. 1988: Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(4): 237-240
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Kudrin, A.N.; Kogan, A.K.; Korolev, V.V.; Nikolaev, S.M.; Beskrovnova, N.N. 1978: Free-radical lipid oxidation in the pathogenesis of myocardial infarct and the therapeutic and prophylactic role of antioxidants, sodium selenite and its combination with vitamin e Kardiologiia 18(2): 115-118
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19